Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Kingdon Capital

Investor type Hedge Fund


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 17
Average round size
The average size of a deal this fund participated in
Portfolio companies 15
Rounds per year 0.44
Lead investments 3
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 10
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Medical
  • Pharmaceutical
  • Health Care
  • Telecommunications

Kingdon Capital is the famous Corporate Investor, which was founded in 1983. The leading representative office of defined Corporate Investor is situated in the New York. The company was established in North America in United States.

The higher amount of exits for fund were in 2015. Considering the real fund results, this Corporate Investor is 0 percentage points less often commits exit comparing to other organizations. This Kingdon Capital works on 51 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2017. The fund is constantly included in less than 2 investment rounds annually.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Kingdon Capital, startups are often financed by North Bridge Venture Partners & Growth Equity, Battery Ventures, Viola Ventures. The meaningful sponsors for the fund in investment in the same round are Viola Ventures, Van Wagoner Ventures, LLC, North Bridge Venture Partners & Growth Equity. In the next rounds fund is usually obtained by Wellington Financial, Visa International Service Association, Viola Ventures.

Among the most successful fund investment fields, there are E-Commerce, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Luminous Networks, SandCraft, Napo Pharmaceuticals. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Kingdon Capital:
Typical Co-investors
Kingdon Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Kingdon Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ali Chuangtou China, Hangzhou, Zhejiang
AVP Holdings -
Bonsal Capital Baltimore, Maryland, United States
Chant Venture Fund Australia, New South Wales, Sydney
Coeur Mining Inc. Chicago, Illinois, United States
Cortado Ventures Oklahoma, Oklahoma City, United States
Farnam Street Financial Minnesota, Minnetonka, United States
Freelands Group -
Guardian Life Insurance Company - Dental Service Organization New York, New York, United States
Hasso Plattner Institute Brandenburg, Germany, Potsdam
India Technology Fund -
Jinpengjia Holdings -
Linghao Touzi China, Shanghai
MVP Capital Pennsylvania, Radnor, United States
Shanda Capital China, Shanghai
Shanghai Pu Xin Fund Management Changning, China, Shanghai
St. Paul Fire and Marine Insurance Company Minnesota, Saint Paul, United States
Standard Life City of Edinburgh, Scotland, United Kingdom
Westlake Ventures California, Redwood City, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Sapience Therapeutics

$41M31 May 2022 New York, United States

Shoreline Biosciences

Life Science
$140M02 Nov 2021 San Diego, California, United States

Jasper Therapeutics

Health Care
$100M27 Sep 2021 Latvia, Courland, Latvia


Health Care
Medical Device
$115M13 Apr 2021 Lucerne, Switzerland

Imago BioSciences

Life Science
$80M19 Nov 2020 California, United States


$60M05 Dec 2019 Buffalo, New York, United States

Stealth BioTherapeutics

$100M18 Jun 2018 Newton, Massachusetts, United States

SteadyMed Therapeutics

Health Care
$30M23 Apr 2017 Tel Aviv-Yafo, Tel Aviv District, Israel

Napo Pharmaceuticals

Health Care
$2M03 Jan 2017 San Francisco, California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Kingdon Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: